Optometrists in Bloomfield, CT Accepting Medicare

8 Optometrists found. Showing 1 - 8

Ericarect Optometrist Medicare: Medicare Enrolled Practice Location: 11 Mountain Ave, Ste 308, Bloomfield, CT 06002 Phone: 860-943-1997    Fax: 860-943-1990

Satvinder Kaur Sodhi, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 38 Tunxis Ave Ste 1, Bloomfield, CT 06002 Phone: 860-243-2508    Fax: 860-243-9332

Dr. Sheri M. Sparks, OD Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 4 Northwestern Dr Ste 400, Bloomfield, CT 06002 Phone: 860-243-2020    Fax: 860-243-5190

Doctor Anthony Gioscia Optometrist Llc Optometrist Medicare: Medicare Enrolled Practice Location: 397 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-243-8003

Family Optometric Care Pc Optometrist Medicare: Medicare Enrolled Practice Location: 38 Tunxis Ave, Suite 1, Bloomfield, CT 06002 Phone: 860-243-2508

John Mark Lertora, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 38 Tunxis Ave, Suite 1, Bloomfield, CT 06002 Phone: 860-243-2508    Fax: 860-243-9332

Dr. Bradford Alan Newman, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 38 Tunxis Ave, Suite 1, Bloomfield, CT 06002 Phone: 860-243-2508    Fax: 860-243-9332

Connecticut Vision Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 812 Park Ave, Bloomfield, CT 06002 Phone: 860-769-2020

News Archive

ANTRUK awards first research contract to Evotec to find ways of breaking antibiotic resistance

Thanks to the generosity of its donors, Antibiotic Research UK – the world's first charity established to fight antibiotic resistance, provide patient support and raise awareness of the issue of antibiotic resistance – has awarded its first research contract to Evotec, a leading organisation in drug discovery and development.

Study reveals ineffectiveness of insulin and metformin against inflammatory biomarkers

In patients with recent onset type-2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study in the September 16 issue of JAMA.

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term.

Controlling neural excitations may help prevent detrimental effects like those in stroke, say scientists

What do lasers, neural networks, and spreading epidemics have in common? They share a most basic feature whereby an initial pulse can propagate through a medium - be it physical, biological or socio-economic, respectively. The challenge is to gain a better understanding - and eventually control - of such systems, allowing them to be applied, for instance to real neural systems. This is the objective of a new theoretical study published in EPJ B by Clemens Bachmair and Eckehard Schöll from the Berlin University of Technology in Germany.

Read more Medical News

› Verified 1 days ago